Electrophysiology Guided Defibrillator Implantation Early After ST Elevation Myocardial Infarction.
Summary of "Electrophysiology Guided Defibrillator Implantation Early After ST Elevation Myocardial Infarction."
: Sudden death risk is highest early post myocardial infarction. Inducible ventricular tachycardia (VT) confers increased risk of spontaneous ventricular arrhythmias.
: To evaluate outcomes of electrophysiology (EP) guided defibrillator implantation early after ST elevation myocardial infarction (MI) in patients with ejection fraction = 40%.
: EP study performed at 9 days post MI (n=360). Pre-discharge defibrillator recommended if VT >/= 200 ms cycle length induced with = 4 extra-stimuli (EP positive, n=142). EP negative patients discharged without a defibrillator (n=218). Primary endpoint was either sudden death or spontaneous ventricular arrhythmia.
: Defibrillator implanted in 71% of EP(pos) (median 21 d post MI) and withheld in 94% of EP(neg) patients. At 2 years, primary endpoint was 4.3% in EP (neg) and 22% in EP(pos) group (adjusted hazard ratio [HR] 0.46, p=0.035, EP(neg) vs. EP(pos)). Lack of a defibrillator in EP(pos) patients conferred a 4 fold increase risk of sudden death (P=.014). EP(neg) patients without a defibrillator were at significantly lower risk of primary endpoint than EP(pos) patients without a defibrillator (adjusted HR 0.34, P=0.011). Short inducible VT cycle length (200-230 ms) and use of the 4(th) extra-stimulus identified patients at significant arrhythmic risk.
: An EP study performed early after MI identified patients at significant long term arrhythmic risk at a critical time post MI in whom defibrillator implantation was protective. A large majority of patients (EP negative; 2/3(rd)) were at significantly lower risk of arrhythmic events without a defibrillator in the long term.
Department of Cardiology, Westmead Hospital, Sydney, Australia.
This article was published in the following journal.
Name: Heart rhythm : the official journal of the Heart Rhythm Society
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/20650333
- DOI: http://dx.doi.org/10.1016/j.hrthm.2010.07.019
Medical and Biotech [MESH] Definitions
Infections resulting from the implantation of prosthetic devices. The infections may be acquired from intraoperative contamination (early) or hematogenously acquired from other sites (late).
Anterior Wall Myocardial Infarction
MYOCARDIAL INFARCTION in which the anterior wall of the heart is involved. Anterior wall myocardial infarction is often caused by occlusion of the left anterior descending coronary artery. It can be categorized as anteroseptal or anterolateral wall myocardial infarction.
Endometrial implantation of EMBRYO, MAMMALIAN at the BLASTOCYST stage.
Embryo Implantation, Delayed
Delay in the attachment and implantation of BLASTOCYST to the uterine ENDOMETRIUM. The blastocyst remains unattached beyond the normal duration thus delaying embryonic development.
The study of the electrical activity and characteristics of the HEART; MYOCARDIUM; and CARDIOMYOCYTES.
A 57-year-old man was referred for implantation of a dual-chamber implantable cardioverter defibrillator as secondary prevention of sudden cardiac death. During implantation, wandless telemetry was us...
Cornerstones in the treatment of coronary artery disease (CAD) are medical therapy and coronary revascularization. In acute settings (ST-elevation myocardial infarction and non-ST-elevation myocardial...
We tested whether an assessment of myocardial scarring by cardiac magnetic resonance imaging (MRI) would improve risk stratification in patients evaluated for implantable cardioverter-defibrillator (I...
A 41-year-old man underwent implantation of a right-sided implantable cardioverter defibrillator after removal of an infected left-sided system. Defibrillation threshold (DFT) testing on the right-sid...
BACKGROUND: Determination of the defibrillation safety margin (DSM) is the most common method of testing device effectiveness at the time of implantation of implantable cardioverter defibrillator (ICD...
The ADMIRAL (Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction) study demonstrated that early administration of abciximab in patients with ST...
In this trial, the investigators will evaluate the effect of thrombus aspiration followed by stent implantation in improving myocardial blush grade in patients with acute non-ST-elevation...
Of estimated 140,000 cases of acute myocardial infarction admitted to hospitals in Germany per year, approximately 50% present with Non-ST-elevation myocardial infarction (NSTEMI). The cur...
Of the patients who survive hospitalization after an acute myocardial infarction, ca. 10% die of sudden cardiac death in the following 2 years. The prognosis appears not improved by medica...
The purpose of the study id to demonstrate an advantage for intra-vascular ultrasound (IVUS) optimized drug-eluting stent (DES) implantation compared to angiography in complex lesions